Orum Therapeutics, Inc. (KOSDAQ:475830)
86,300
+8,700 (11.21%)
Apr 10, 2026, 3:30 PM KST
265.68% (1Y)
| Market Cap | 1.83T +190.9% |
| Revenue (ttm) | 23.56M -99.9% |
| Net Income | -41.97B |
| EPS | -2,017.00 |
| Shares Out | 21.23M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 357,800 |
| Average Volume | 291,821 |
| Open | 79,500 |
| Previous Close | 77,600 |
| Day's Range | 79,000 - 88,100 |
| 52-Week Range | 15,950 - 146,600 |
| Beta | n/a |
| RSI | 40.88 |
| Earnings Date | Apr 3, 2026 |